| 持有 万泰生物(603392)的基金 |
| 报告期：2022-09-30 |
| 序号 |
基金代码 |
基金简称 |
持仓市值(元) |
持仓数量(股) |
占基金净值比例(%) |
| 1 | 161726 | 招商国证生物医药指数分级 | 476,681,920.00 | 4,166,800.00 | 3.54 |
| 2 | 000960 | 招商医药健康产业股票 | 201,454,739.20 | 1,760,968.00 | 7.37 |
| 3 | 009275 | 融通医疗保健行业混合C | 80,089,380.80 | 700,082.00 | 5.83 |
| 4 | 161616 | 融通医疗保健行业混合A | 80,089,380.80 | 700,082.00 | 5.83 |
| 5 | 003231 | 创金合信医疗保健股票C | 77,115,324.00 | 674,085.00 | 7.77 |
| 6 | 003230 | 创金合信医疗保健股票A | 77,115,324.00 | 674,085.00 | 7.77 |
| 7 | 009361 | 招商创新增长混合C | 45,294,048.80 | 395,927.00 | 6.88 |
| 8 | 009360 | 招商创新增长混合A | 45,294,048.80 | 395,927.00 | 6.88 |
| 9 | 010586 | 创金合信医药消费股票C | 29,449,992.00 | 257,430.00 | 7.60 |
| 10 | 010585 | 创金合信医药消费股票A | 29,449,992.00 | 257,430.00 | 7.60 |
| 11 | 161122 | 易方达生物科技指数分级 | 22,125,417.60 | 193,404.00 | 2.23 |
| 12 | 009779 | 长信消费升级混合C | 19,043,024.00 | 166,460.00 | 6.61 |
| 13 | 009778 | 长信消费升级混合A | 19,043,024.00 | 166,460.00 | 6.61 |
| 14 | 004221 | 长信量化先锋混合C | 13,025,584.00 | 113,860.00 | 1.90 |
| 15 | 519983 | 长信量化先锋混合A | 13,025,584.00 | 113,860.00 | 1.90 |
| 16 | 163001 | 长信医疗保健混合(LOF) | 11,648,208.00 | 101,820.00 | 6.03 |
| 17 | 000219 | 博时裕益混合 | 8,291,140.00 | 72,475.00 | 3.92 |
| 18 | 519959 | 长信多利混合 | 6,934,356.00 | 60,615.00 | 6.46 |
| 19 | 510660 | 华夏医药ETF | 2,093,863.20 | 18,303.00 | 2.17 |
| 20 | 161037 | 富国中证高端制造指数增强型(LOF) | 1,545,544.00 | 13,510.00 | 1.44 |
| 21 | 519987 | 长信恒利优势混合 | 1,273,958.40 | 11,136.00 | 5.97 |
| 22 | 004606 | 上投摩根优选多因子股票 | 164,850.40 | 1,441.00 | 1.94 |
| 23 | 004918 | 中银证券祥瑞混合C | 161,876.00 | 1,415.00 | 1.94 |
| 24 | 004917 | 中银证券祥瑞混合A | 161,876.00 | 1,415.00 | 1.94 |
| 25 | 007580 | 宝盈中证100指数增强C | 148,720.00 | 1,300.00 | 0.07 |
| 26 | 213010 | 宝盈中证100指数增强A | 148,720.00 | 1,300.00 | 0.07 |
| 27 | 005902 | 诺安汇利混合C | 57,200.00 | 500.00 | 0.09 |
| 28 | 005901 | 诺安汇利混合A | 57,200.00 | 500.00 | 0.09 |
